India-Malaysia Harimau Shakti: Joint Military Exercise 2024

The India-Malaysia Harimau Shakti Joint Military Exercise 2024, held in Bentong Camp, Malaysia, aims to enhance joint military capabilities for counter-insurgency operations, implement United Nations Chapter VII Mandate, and develop inter-operability between armies.

Exercise Overview and Participation

4th edition of India-Malaysia Joint Military Exercise Harimau Shakti 2024
Venue: Bentong Camp, Pahang District, Malaysia
Duration: 2nd to 15th December 2024
Indian Contingent: 78 personnel from Mahar Regiment
Malaysian Contingent: 123 personnel from Royal Malaysian Regiment
Annual training event alternating between India and Malaysia
Last edition held in Umroi Cantonment, Meghalaya in November 2023

Exercise Objectives and Methodology Primary Aims:

Enhance joint military capability for counter-insurgency operations
Undertake operations in jungle terrain
Implement United Nations Chapter VII Mandate
Develop inter-operability between armies

Exercise Structure:

Two-phase operational approach

Phase 1: Cross-training

- Lectures
- Demonstrations
- Jungle terrain drill practices

Phase 2: Simulated Exercise

- Anti-MT Ambush
- Harbour Occupation
- Reconnaissance Patrol
- Terrorist Area Attack Simulation

Bilateral Defence Cooperation Context Historical Diplomatic Relations:

Diplomatic relationship established in 1957
Upgraded to Comprehensive Strategic Partnership in August 2024
Defence cooperation cornerstone: 1993 MoU on Defence Cooperation

Bilateral Military Exercises:

Harimau Shakti (Army)
Samudra Laksamana (Naval)
Udan Shakti (Air Force)

Key Exercise Significance:

Sharing best practices
Developing military camaraderie
Enhancing bilateral relations
Promoting global peace
Demonstrating multinational military collaboration

Theme for 2024: "Two nations, one mission: Ensuring global peace"

Exercise Outcomes:

Improved military interoperability
Enhanced tactical understanding
Strengthened diplomatic ties
Mutual skill development
Practical counter-insurgency training

SEBI Action on Jane Street

In one of the most significant regulatory crackdowns in Indian financial history, the SEBI action on Jane Street has grabbed headlines and raised critical discussions around foreign investment, ma

Rwanda-Congo Peace Deal

In a major diplomatic development, Rwanda and the Democratic Republic of Congo (DRC) signed the historic Rwanda-Congo peace deal in 2025. This US-brokered peace agreement aims to end deca

India Rejects SCO Joint Statement

India rejects SCO joint statement – this powerful decision echoed globally after India’s Defence Minister refused to sign the final declaration at the SCO 2025 Summit in Qingdao, China

Unsafe Generic Chemotherapy Drugs

Recent investigations have uncovered serious quality issues in generic chemotherapy drugs used for cancer treatment across more than 100 countries. This has raised alarms over the safety, effe

NATO Defence Spending 2025

The NATO defence spending 2025 summit has marked a historic turning point in the alliance’s approach to global defence and military funding. Under the leadership of former U.S. President

Operation Bashayer Al-Fath

On June 23, 2025, the Middle East witnessed a major escalation as Iran launched Operation Bashayer Al-Fath, a powerful missile assault targeting the US Al-Udeid Air Base in Qatar. This developm

GENIUS Act 2025 Highlights

The GENIUS Act 2025, passed by the US Senate in June 2025, represents a significant legislative step in cryptocurrency regulation, with a widespread impact on stablecoins, digi

US-Iran Nuclear Conflict 2025

On June 22, 2025, the United States launched targeted airstrikes on three major Iranian nuclear facilities—Fordow, Isfahan, and Natanz—escalating what is now widely recognized as the U

Iran Uranium Enrichment

The ongoing tension between Iran, Israel, and the United States has taken a serious turn, primarily due to Iran's uranium enrichment issue. The situation surrounding Iran’s Fordow nuclea

Yeztugo HIV Injection

In a historic development in the fight against HIV, the United States Food and Drug Administration (US FDA) has approved Yeztugo HIV injection—a revolutionary drug for the long-acting preven